1. INTRODUCTION
1.1. Market Overview
1.2. Market Definition
1.3. Scope of the Study
1.4. Market Segmentation
1.5. Currency
1.6. Assumptions
1.7. Base and Forecast Years Timeline
1.8. Key benefits for the stakeholders
2. RESEARCH METHODOLOGY
2.1. Research Design
2.2. Research Process
3. EXECUTIVE SUMMARY
3.1. Key Findings
4. MARKET DYNAMICS
4.1. Market Drivers
4.2. Market Restraints
4.3. Porter’s Five Forces Analysis
4.3.1. Bargaining Power of Suppliers
4.3.2. Bargaining Power of Buyers
4.3.3. The Threat of New Entrants
4.3.4. Threat of Substitutes
4.3.5. Competitive Rivalry in the Industry
4.4. Industry Value Chain Analysis
4.5. Analyst View
5. PRECISION MEDICINE SOFTWARE MARKET BY DEPLOYMENT
5.1. Introduction
5.2. Cloud
5.3. On-Premise
6. PRECISION MEDICINE SOFTWARE MARKET BY APPLICATIONS
6.1. Introduction
6.2. Oncology
6.3. Central Nervous System
6.4. Immunology
6.5. Cardiovascular
6.6. Others
7. PRECISION MEDICINE SOFTWARE MARKET BY END-USER
7.1. Introduction
7.2. Hospitals and Clinics
7.3. Pharmaceutical Research Institute
7.4. Others
8. PRECISION MEDICINE SOFTWARE MARKET BY GEOGRAPHY
8.1. Introduction
8.2. North America
8.2.1. By Deployment
8.2.2. By Application
8.2.3. By End User
8.2.4. By Country
8.2.4.1. United States
8.2.4.2. Canada
8.2.4.3. Mexico
8.3. South America
8.3.1. By Deployment
8.3.2. By Application
8.3.3. By End User
8.3.4. By Country
8.3.4.1. Brazil
8.3.4.2. Argentina
8.3.4.3. Others
8.4. Europe
8.4.1. By Deployment
8.4.2. By Application
8.4.3. By End User
8.4.4. By Country
8.4.4.1. Germany
8.4.4.2. Spain
8.4.4.3. United Kingdom
8.4.4.4. France
8.4.4.5. Others
8.5. Middle East and Africa
8.5.1. By Deployment
8.5.2. By Application
8.5.3. By End User
8.5.4. By Country
8.5.4.1. Saudi Arabia
8.5.4.2. South Africa
8.5.4.3. Others
8.6. Asia Pacific
8.6.1. By Deployment
8.6.2. By Application
8.6.3. By End User
8.6.4. By Country
8.6.4.1. China
8.6.4.2. Japan
8.6.4.3. Australia
8.6.4.4. India
8.6.4.5. South Korea
8.6.4.6. Indonesia
8.6.4.7. Others
9. COMPETITIVE ENVIRONMENT AND ANALYSIS
9.1. Major Players and Strategy Analysis
9.2. Market Share Analysis
9.3. Mergers, Acquisitions, Agreements, and Collaborations
9.4. Competitive Dashboard
10. COMPANY PROFILES
10.1. Accenture
10.2. Wipro
10.3. Intel
10.4. GenomOncology LLC
10.5. Precision Medicine Group, LLC.
10.6. Tempus
10.7. Genomind
10.8. Syapse Holdings, Inc.
10.9. Foundation Medicine, Inc.
10.10. 2bPrecise
10.11. Koninklijke Philips N.V
10.12. Cision US Inc.
10.13. Genedata AG
10.14. Ariel Precision Medicine
10.15. Integrate.AI Inc.